Hpv infection Clinical Trials
Conditions / Hpv infection
Delta Trials records 108 clinical trials for Hpv infection in its publicly accessible dataset. From the full dataset, 32 actively seeking eligible participants and 34 trials have reached completion. This research is conducted across 166 study locations around the world. An additional 42 trials are active but not currently open for enrollment. Since 2020, 1 trial have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
108
Total Trials
32
Recruiting
34
Completed
42
Other Active
1
Terminated since 2020
166
Study Locations
Browse by location (166 total)
- Fuzhou, China 7 trialsAll trials in Fuzhou, China
- Ningde, China 6 trialsAll trials in Ningde, China
- Wuhan, China 6 trialsAll trials in Wuhan, China
- Shenzhen, China 6 trialsAll trials in Shenzhen, China
- Zhangzhou, China 5 trialsAll trials in Zhangzhou, China
- Putian, China 4 trialsAll trials in Putian, China
- Xiamen, China 4 trialsAll trials in Xiamen, China
- Longyan, China 4 trialsAll trials in Longyan, China
- Quanzhou, China 4 trialsAll trials in Quanzhou, China
- Beijing, China 3 trialsAll trials in Beijing, China
- Sanming, China 3 trialsAll trials in Sanming, China
- Ghent, Belgium 3 trialsAll trials in Ghent, Belgium
- Boston, United States 3 trialsAll trials in Boston, United States
- Seattle, United States 3 trialsAll trials in Seattle, United States
- Cleveland, United States 2 trialsAll trials in Cleveland, United States
- Haiphong, Vietnam 2 trialsAll trials in Haiphong, Vietnam
- Kakumiro, Uganda 2 trialsAll trials in Kakumiro, Uganda
- São Paulo, Brazil 2 trialsAll trials in São Paulo, Brazil
- Cuernavaca, Mexico 2 trialsAll trials in Cuernavaca, Mexico
- São Paulo, Brazil 2 trialsAll trials in São Paulo, Brazil